There are no buyer coming in as volume is anemic. It is obvious that SequestOx will not get Abuse deterrent labeling. FDA is clear when they denied KMPH abuse deterrent labeling. Any technology that does not address core issue of addiction through ingestion will not be allowed ADL. Insurance companies will not reimburse without ADL. ELTP will crash without Abuse deterrent labeling same as KMPH. ELTP is just another company that claim Abuse deterrent technology without solving the main problem, Opioid Ingestion.